New therapeutic approaches for the treatment of Brucella infections: Gentamicin entrapment into drug delivery systems

Current Medicinal Chemistry: Anti-Infective Agents

Volumn 3, Issue 1, 2004, Pages 43-56

  Gamazo, Carlos ^a   Blanco Prieto, María José ^a   Lecároz, María Concepción ^a   Vitas, Ana Isabel ^a   Gander, Bruno ^b   Irache, Juan Manuel ^a   Prior, Sandra ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b ETH ZURICH   (Switzerland)

Author keywords

Biodegradable microspheres; Brucella infected mice; Brucella infected monocytes; Brucellosis; Drug delivery systems; Gentamicin sulphate; Liposome stability

Indexed keywords

GENTAMICIN; LIPOSOME; MICROSPHERE; POLYGLACTIN; POLYLACTIDE; SEPHADEX;

ANTIBACTERIAL ACTIVITY; BRUCELLA ABORTUS; BRUCELLOSIS; CELL KILLING; CHEMICAL COMPOSITION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; ENCAPSULATION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; REVIEW;

EID: 3042743865     PISSN: 15680126     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568012043354125     Document Type: Review

References (150)

1. FAO-WHO Expert Committee on brucellosis sixth report. World Health Organization Technical Report Series 740. Food and Agriculture Organization-World Health Organization. WHO, Geneva, 1996.
2. Blasco, J.M. In Animal Brucellosis; Nielsen, K.; Duncan, J.R. Eds.; CRC Press: Boca Raton, Florida, 1990, 351.
3. Young, E.J. Clin. infect. Dis., 1995, 21, 283.
4. Solera, J.; Lozano, E.; Martinez-Alfaro, E.; Espinosa, A.; Catillejos, M.L.; Abad, L. Clin. Infect. Dis., 1999, 29, 1440.
5. Man-huei, C.; Glynn, M.K.; Groseclose, S.L. Emerg. Infect. Dis., 2003, 9(5), 556.
6. U.S. Department of Health and Human Services/CDC and National Institutes of Health. In Biosafety in Microbiological and Biomedical Laboratories.; Richmond, J.Y.; McKinney, R.W. Eds.; U.S. Department of Health and Human Services: Washington DC, 1999; Appendix A
7. Liautard, J.P.; Gross, A.; Dornand, J.; Köhler, S. Microbiol. SEM, 1996, 12, 197.
8. Pizarro-Cerda, J.; Meresse, S.; Parton, R.G.; van der Goot, G.; Sola-Landa, A.; Lopez-Goni, I.; Moreno, E.; Gorvel, J.P. Infec. Immun., 1998, 66 (12), 5711.
9. Hall, W.H. Rev. Infect. Dis., 1990, 12, 1060.
10. Ariza, J.; Corredoira, J.; Pallarés, R.; Viladrich, P.F.; Rufi, G.; Pujol, M.; Gudiol, F. Clin. Infect. Dis., 1995, 20, 1241.
11. Montejo, J.M.; Alberola, I.; Glez-Zárate, P.; Alvarez, A.; Alonso, J.; Cánovas, A.; Aguirre, C. Clin. Infect. Dis., 1993, 16, 671.
12. Ariza, J.; Gudiol, F.; Pallarés, R.; Rufi, G.; Fernández-Viladrich, P. Antimicrob. Agents Chemother., 1985, 28, 548.
13. Ariza, J., Gudiol, F.; Pallarés, R.; Viladrich, P.F.; Rufi, G.; Corredoira, J.; Miravitlles, M.R. Ann. Intern. Med., 1992, 117, 25.
14. Domingo, I.; Gastearena, A.; Vitas, A.I.; López-Goñi, I.; Dios-Viéitez, C.; Díaz, R.; Gamazo, C. J. Antimicrob. Chemother., 1995, 36, 647.
15. Solera, J., Rodríguez-Zapata, M.; Geijo, P.; Larfo, J.; Paulino, J.; Sáez, L.; Martínez-Alfaro, E.; Sá nchez, L.; Sepúlveda, M.A.; Ruiz-Ribó, M.D.; GECMEI group. Antimicrob. Agents Chemother., 1995, 39, 2061.
16. Alton, G.G.; Plommet, M. Brucellosis Summit in Geneva. WHO Chronicle, 1986, 40 (1), 19.
17. Solera, J., Martínez-Alfaro, E.; Espinosa, A. Drugs, 1997, 53 (2), 245.
18. Lubani, M.; Dudin, K.K.; Sharda, D.C.; Mana Ndhar, D.S.; Araj, G.F.; Hafez, G.A.; Q-Saleh, Q.A.; Helin, I.; Salhi, M.M. J. Pediatr. Infect. Dis., 1989, 8, 75.
19. Kreuter, J. Infection, 1991, 19 Suppl. 4, S224.
20. Bakker-Woudenberg, I.A.; Lokerse A.F.; ten Kate, M.T.; Melissen, P.M.; van Vianen, W.; van Etten, E.W. Eur. J. Clin. Microbiol. Infect. Dis. 1993, 12 Suppl. 1, S61.
21. Puisieux, F.; Barrat, G.; Couarraze,G.; Couvreur, P.; Devissaguet, J.P; Duvernett, C.; Fattal, E.; Fessi, H,; Vauthier, C.; Benita, S. In Polymeric Biomaterials; Dumitri, Ed.; Marcel Decker Inc.: New York, 1994, pp. 749.
22. Poste, G. In Liposomes in biological systems; Gregoriadis, Allison Eds.; J. Wiley & Sons, New York. 1980; pp. 101-51.
23. Dees, C.; Fountain, M.W.; Taylor, I.R.; Shultz, R.D. Vet. Immunol. Immunopathol., 1985, 8, 171.
24. Fountain, M.W.; Weis, S.J.; Fountain, A.G.; Shen, A.; Lenk, R. P. J. Infect. Dis., 1985, 152, 529.
25. Hernández-Caselles T.; Vera, A.; Crespo, F.; Villalaín, J.; Gómez-Fernández, J.C. Am. J. Vet. Res., 1989, 50, 1486.
26. Vitas, A.I.; Díaz, R.; Gamazo, C. Antimicrob. Agents. Chemother., 1996, 40, 146.
27. Vitas A.I.; Díaz; R. Gamazo, C. Chemotherapy, 1997, 43, 204.
28. Forestier, F.; Gerrier, P.; Chaumard, C.; Quero, A.M.; Couvreur, P.; Labarre, C. J. Antimicrob. Chemother., 1992, 30, 173.
29. Bakker-Woundenberg, I.A.J.M.; Lokerse, A.F.; Roerdink, F.H.; Regts, D. Michel, M.F. J. Infect. Dis., 1985, 151, 917
30. Fattal, E.; Rojas, J.; Youseff, M.; Couvreur, P.; Andremont, A. Antimicrob. Agents Chemother., 1991, 35, 770.
31. Fattal, E.; Youseff, M.; Couvreur, P.; Andremont, A. Antimicrob. Agents Chemother., 1989, 33, 1540.
32. Majumdar, S.; Flasher, D.; Friend, D.S.; Nassos, P.; Yajko, D.; Hadley W.K.; Düzgünes, N. Antimicrob. Agents. Chemother., 1992, 36, 2808.
33. Barrow, E.L.W.; Winchester, G.A.; Staas, J.K.; Quenelle, D.C.; Barrow, W.W. Antimicrob. Agents Chemother., 1998, 42, 2682.
34. Dutt, M.; Khuller, G.K. Antimicrob. Agents Chemother., 2001, 45, 363.
35. Quenelle, D.C.; Winchester, G.A.; Staas, J.K.; Barrow, E.L.W.; Barrow, W.W. Antimicrob. Agents Chemother., 2001, 45, 1637.
36. Yanagihara, K. Curr. Pharm. Design, 2002, 8, 475.
37. Tulkens, P.M. Am. J. Med., 1986, 80(6B), 105.
38. Tardif, D.; Beauchamp, D.; Bergeron, M.G. Antimicrob. Agents Chemother., 1990, 34, 576.
39. Gargani, G.; Pacetti, A.M. Chemioterapia, 1998, 5(1), 7.
40. Carrillo, C.E.; Gotuzzo, J.; Adachi, J.; Tolmos, J. Rev. Esp. Quimioter., 1993, 6, 309
41. New, R.R.C.; In Liposomes: a Practical Approach, New, R.C.C., Ed; IRL Press: Oxford, 1990, pp. 33.
42. Gregoriadis, G. N. Engl. J. Med., 1976, 295, 704.
43. Gregoriadis, G. J. Antimicrob. Chemother., 1991, 28, Suppl B, 39.
44. Morgan, J.R.; Williams, K.E. Antimicrob. Agents Chemother., 1980, 17(4), 544.
45. Fountain, M.W; Weiss, S.J.; Fountain, A.G.; Shen, A.; Lenk, R.P. J. Infect. Dis., 1985, 152(3), 529.
46. Karlowsky, J.A.; Zhanel, G.G. Clin. Infect. Dis., 1992, 15(4), 654.
47. Bakker-Woundenberg, I.A.J.M.; ten Kate, M.T.; Stearne-Cullen, L.E.T.; Woodle, M.C. J. Infect. Dis., 1995, 171, 938.
48. Lutwyche, P. Cordeiro, C.; Wiseman, D.J.; St-Louis, M.; Uh, M.; Hope, M.J.; Webb, M.S.; Finlay, B.B. Antimicrob. Agents Chemother., 1998, 42(10), 2511.
49. Pinto-Alphandary, H.; Andremont, A.; Couvreur, P. Int. J. Antimicrob. Agents, 2000, 13(1), 155.
50. Maurin, M.; Raoult, D. Antimicrob. Agents Chemother., 2001, 45(11), 2977.
51. Schiffelers, R.; Storm, G.; Bakker-Woudenberg, I. J. Antimicrob. Chemother., 2001, 48(3), 333.
52. Fierer, J.; Hatlen, L.; Lin, J.P.; Estrella, D.; Ihalko, P.; Yau-Young, A. Antimicrob, Agents Chemother, 1990, 32, 343.
53. Bakker-Woundenberg, I.A.J.M.; Lokerse, A.F.; Vink-van den Berg J.C.; Roerink, F.H. Infection, 1988, 16, S-165.
54. Elorza, B.; Elorza, M.A.; Sainz, M.C.; Chantres, J.R. J. Microencapsul., 1993, 10(2), 237.
55. Elorza, B.; Elorza, M.A.; Sainz, M.C.; Chantres, J.R., J. Pharm. Sci., 1993, 82(11), 1160.
56. Benson, J.R.; Hare, P.E. Proc. Nat. Acad. Sci. USA, 1975, 72, 619.
57. Gruner, S.M.; Lenk, R.P.; Janoff, A.S.; Ostro, M., J. Biochem., 1985, 24, 2833.
58. Alving, C.R.; Swartz, G.M. Jr. In Liposome Technology; Gregoriadis, G., Ed.; CRC Press Inc.: Boca Ratón, Florida, 1984; Vol. II, pp. 55-68.
59. Prior, S. Development and evaluation of galenical formulations for the treatment of brucellosis, Ph D. thesis: University of Navarra, Pamplona, Spain, 2000.
60. Mayer, L.D.; Hope, M.J.; Cullis, P.R.; Janoff, A.S. Biochim. Biophys. Acta, 1985, 817(1), 193.
61. Castile, J.D.; Taylor, K.M. Int. J. Pharm., 1999, 188(1), 87.
62. Harashima H, Huong TM, Ishida T, Manabe Y, Matsuo H, Kiwada H. Pharm. Res., 1996, 13(11), 1704.
63. Liu, D.; Mori, A.; Huang, L. Biochim. Biophys. Acta, 1991, 1066(2), 159.
64. Hope, M.J.; Bally, M.B.; Webb, G.; Cullis, P.R. Biochim. Biophys. Acta, 1985, 812, 55.
65. Mayer, L.D.; Hope, M.J., Cullis, P.R. Biochim. Biophys. Acta, 1986, 858(1), 161.
66. Gregoriadis, G.; da Silva, H.; Florence, A.T. Int. J. Pharm., 1990, 65, 235.
67. Ruijgrok, E.J.; Vulto, A.G.; van Etten, E.W.M. J. Liposome Res., 1999, 9, 291.
68. Weinstein, J.N.; Yoshikami, S.; Henkart, P.; Blumenthal, R.; Hagins,W.A. Science, 1977, 195, 489.
69. Szoka, F.C. Jr.; Jacobson, K.; Papahadjopoulos, D. Biochim. Biophys. Acta, 1979, 551, 295.
70. Allen, T.M.; Cleland, L. G. Biochim. Biophys. Acta, 1980, 597, 418.
71. Mingeot-Leclerq, M.P.; Schank, A.; Ronveaux-Dupal, M.F.; Brasseur, R.; Ruysscahert, J.M.; Laurent, G.; Tulkens, P.M., Biochem. Pharmacol., 1989, 38, 729.
72. Kubo, M.; Gardner, M.F.; Hostetler, K.Y. Biochem. Pharmacol., 1986, 35, 3761.
73. Hope, M.J.; Bally, M.B.; Mayer, L.D.; Janoff, A.S.; Cullis, P.R. Chem. Phys. Lipids, 1986, 40, 89
74. Lichtemberg, D.; Markello, T. J. Pharm. Sci., 1984, 73, 122.
75. Madden, T.D.; Bally, M.B.; Hope, M.J.; Cullis, P.R.; Schieren, H.P.; Janoff, A.S. Biochim. Biophys. Acta, 1985, 817(1), 67.
76. Lasic, D.D. J. Biochem., 1988, 256(1), 1.
77. Mingeot-Leclerq, M.P.; Laurent, G.; Tulkens, P.M. Biochem. Pharmacol., 1988, 37, 591.
78. Scherphof, G.; Vaneleuwen, B.; Wilschut, J., Damen, J. Bioehim. Biophys. Acta, 1983, 732, 595.
79. Senior, J.; Gregoriadis, G.; Mitropoulos, K.A. Biochim. Biophys. Acta, 1983, 760, 111.
80. Tall, A. R.; Small, D.M. Nature, 1977, 265, 163.
81. Krupp, L.; Chobanian, A.V.; Brecher, J.P. Biochem. Biophys. Res. Comm., 1976, 72, 1251.
82. Kirby, C.; Gregoriadis, G. Biochem. J., 1981, 199, 251.
83. Absolom, D. R. In Methods in Enzymology; di Sabato, G. and Everse, J. Eds.; Academic Press, Inc.: Toronto, 1986; Vol. 132, pp. 95-180.
84. Allen, T.M. In Liposomes as Drug Carriers. Recent Trends and Progress. Gregoriadis, Ed.; John Wiky & Sons: London, 1988; pp. 37-50.
85. Demel, R. A.; De Kruyff, B. Biochim. Biophys. Acta, 1976, 457, 109.
86. Gregoriadis, G.; Davis, C. Biochem. Biophys. Res. Commun., 1979, 89, 1287.
87. Guo, L.S.S.; Hamilton, R.L.; Goerke, J.; Weinstein, J.N.; Havel, R.J. J. Lipid Res., 1980, 21, 993.
88. Op den Kamp, J.A.F.; Kauerz, M.T.; Van Deenen, L.L.M. Biochim. Biophys. Acta, 1975, 406, 169.
89. Cordeiro, C; Wiseman, D.J.; Lutwyche, P.; Uh, M.; Evans, J.C.; Finlay, B.B.; Webb, M.S. Antimicrob. Agents Chemother., 2000, 44(3), 533.
90. McIntosh, T.J. Biochim. Biophys. Acta, 1978, 513, 43.
91. Vitas, A.I. Desarrollo de una formulación liposomal para el tratamiento y profilaxis de la brucelosis. Ph D. thesis: University of Navarra, Pamplona, Spain, 1994, pp. 106-9.
92. Juliano, R.L. In Liposomes: from physical structure to therapeutic applications; Knight, Ed.; Elsevier/North-Holland 619, Biomedical Press: Amsterdam, 1981; pp. 391-407.
93. Allen, T.M.; Austin, G.A.; Chonn, A.; Lin, L.; Lee, K.C. Biochim. Biophys. Acta, 1991, 1061, 55.
94. Papahadjopoulos, D.; Poste, G.; Schaeffer, B.E. Biochim. Biophys. Acta, 1973, 323, 23.
95. Patel, H.M.; Tuzel, N.S.; Ryman, B.E. Biochim. Biophys. Acta, 1983, 761, 142.
96. Moghimi, S.M.; Patel, H.M. FEBS, 1988, 233, 143.
97. Dijkstra, J.; van Galen, M.; Scherphof, G. Biochim. Biophys. Acta, 1985, 813, 287.
98. Gabizon, A.; Papahadjopoulos, D. Biochim. Biophys. Acta, 1992, 1103, 94.
99. Hsu, M.J.; Juliano, R.L. Biochhn. Biophys. Acta, 1982, 720, 411.
100. Senior, J.H.; Trimble, K. R.; Maskiewicz, R. Biochim. Biophys. Acta, 1991, 1070, 173.
101. Magee, W.E.; Goff, C.W.; Schoknecht, J.; Smith, M.D.; Cherian, K. J. Cell. Biol., 1974, 63, 492.
102. Schwendener, R.A.; Lagocki, P.A.; Rahman, I.E. Biochim. Biophys. Acta, 1984, 772, 93.
103. Mehta, K.; López-Berestein, G.; Hersh, E.M.; Juliano, R.L. J. Reticuloendothel. Soc., 1982, 32, 155.
104. Metha, K.; Juliano, G.R.L.; López-Berestein, G. Immunology, 1984, 51, 512.
105. Morgan, J.R.; Williams, K.E. Antimicrob. Agents Chemother., 1980, 17, 544.
106. Orozco, L.C.; Forero, M.; Wasserman, M.; Ahumada, J.L. Tubercle, 1990, 71, 209.
107. Cynamon, M.H.; Swenson, C.E.; Palmer, G.S.; Ginsberg, R.S. Antimicrob. Agents. Chemother., 1989, 33, 1179.
108. Orozco, L.C.; Quintana, F.; Beltrán, R.M.; de Moreno, I.; Wasserman, M.; Rodríguez, G. Tubercle, 1986, 67, 91.
109. Poste, G. Biol. Cell., 1983, 47, 19.
110. Dijkstra, J.; van Galen, W.J.M.; Hulstaert, C.E.; Kalicharan, D.; Roerdink, F.H.; Scherphof, G. L. Exp. Cell. Res., 1984, 150, 161.
111. Couvreur, P.; Puisieux, F. Adv. Drug Delivery Rev., 1993, 10, 141.
112. Athanesion, K.A.; Niederaner, G.G.; Agrawal, C.M. Biomaterials, 1996, 17, 93.
113. Wada, R.; Hyon, S.H.; Ikada, Y.; Yoshikawa, H.; Muranishi, S. J. Bioact. Compat. Polymer, 1988, 3, 126.
114. Leelarasamee, N.; Howard, S.A.; Malanga, C.J.; Cozzi, L.A.; Hogan, T.F.; Kandzari, S.J.; Ma, J.K. J. Microencapsulation, 1986, 3, 171.
115. Kersten, G.F.A.; Gander, B. In Concepts in Vaccine Development Kaufmann, Ed.; Walter de Gruyter: Berlin, New York, 1996.
116. Pavanetto, F.; Genta, I.; Giunchedi, P.; Conti, B. J. Microencapsul., 1993, 10, 487.
117. Lewis, D.H. In Biodegradable polymers as drug delivery systems. Chasin, M.; Langer, Eds.; Dekker, New York, 1990; pp. 1-41.
118. Thomasin, C.; Corradin, G.; Men, Y.; Merkle, H.P.; Gander, B. J. Controlled Release, 1996, 41, 131.
119. Prior, S.; Gamazo, C.; Irache, J.M.; Merkle, H.P.; Gander, B. Int. J. Pharm. 2000, 196, 115.
120. Gander, B.; Johansen, P.; Nam-Trân, H.; Merkle, H. P. Int. J. Pharm., 1996, 129, 51.
121. Nagata, S.; Takeshima, K.; Hirano, K.; Takagishi, Y. Yakugaku Zasshi, 1994, 114 (12), 1005.
122. Bradfield, W.B.J. In Microspheres and Drug Therapy: Davis, Illum, McVie, Tomlinson, Ed.; Elsevier Science Publishers B.V: Amsterdam, 1984; pp. 25.
123. Rudt, S.; Müller, R.H. J. Controlled Release, 1992, 22, 263.
124. Müller, R.H.; Ruhl, D.; Luck, M.; Paulke, B.R. Pharm. Res., 1997, 14(1), 18.
125. Tabata, Y.; Ikada, Y. Biomaterials, 1988, 9, 356.
126. Tabata, Y.; Ikada, Y. In High Perf. Biomat: Szycher, M. Ed.; Technomic Publishing: Lancaster, Basel, 1991; pp. 621-646
127. O'Brien, C.N.; Guidry, A.J. J. Dairy Sci., 1996, 79, 1954.
128. Evora, C.; Soriano, I.; Rogers, R.A.; Shakesheff, K.M.; Hanes, J.; Langer, R. J. Controlled Release, 1998, 51, 143.
129. Prior, S.; Gander, B.; Blarer, N.; Merkle, H.P.; Subirá, M.L.; Irache, J.M.; Gamazo, C. Eur. J. Pharm. Sci., 2002, 15, 197.
130. Illum, L.; Davis, S.S.; Wilson, C.G.; Thomas, N.W; Frier, M.; Hardy, J.G. Int. J. Pharm., 1982, 12, 135.
131. Illum, L.; Jacobsen, L.O.; Müller, R.H.; Mak, E.; Davis, S.S. Biomaterials, 1987, 8, 113.
132. Müller, R. H. In Colloidal Carriers for Controlled Drug Delivery and Targeting; Müller, R. H. Ed.; Wissenschaftliche Verlagsgesellschaft: Stuttgart, CRC Press: Boca Raton, Ann Arbor, Boston, 1991; pp. 19-41.
133. Murillo, M.; Gamazo, C.; Goñi, M.M.; Irache, J.M.; Blanco-Prieto, M.J. Int. J. Pharm., 2002, 242, 341.
134. Artursson, P.; Arro, E.; Edman, P.; Ericsson, J.L.E.; and Sjöholm, I. J. Pharm. Sci., 1987, 76, 127.
135. Silverstein, S.C.; Steinman, R.M.; Cohn, Z.A. Ann. Rev. Biochem., 1977, 46, 669.
136. Casado, J.A.; Merino, J.; Cid, J.; Subirá, M.L.; Sánchez-Ibarrola, A. Immunology, 1994, 83, 148.
137. Ng, K.-y.; Stringer, K.A.; Cohen, Z.; Serravo, R.; Tian, B.; Meyer, J.D.; Falk, R.; Randolph, T.; Manning, M.C.; Thompson, D.C. Int. J. Pharm., 1998, 170, 41.
138. Smith, A.; Hunneyball, I.M. Int. J. Pharm., 1986, 30, 215.
139. Morin, C.; Barrat, G.; Fessi, H.; Devissaguet, J.P.; Puisieux, F. J. Drug Targeting, 1993, 1, 157.
140. Cruz, T.; Gaspar, R.; Donato, A.; Lopes, C. Pharmaceut. Res., 1997, 14 (1), 73.
141. Rudt, S.; Müller, R.H. J. Controlled Release, 1993, 25, 51-59.
142. Watrous-Peltier, N.; Uhl, J.; Steel, V.; Brophy, L.; Merisko-Liversidge, E. Pharm. Res., 1992, 9, 1177-83.
143. Schäfer, V.; von Briesen, H.; Andreesen, R.; Steffan, A. M.; Royer, C.; Tröster, S.; Kreuter, J.; Rübsamen-Waigmann, H. Pharm. Res., 1992, 9, 541-6.
144. Batrakova, E.; Lee, S.; Li, S.; Venne, A.; Alakhov, V.; Kabanov, A. Pharm. Res., 1999, 16, 1373-9.
145. Miller, D. W.; Batrakova, E. V.; Kabanov, A. V. Pharm. Res., 1999, 16, 396-401.
146. Espuelas, S.; Legrand, P.; Loiseau, P. M.; Bories, C.; Barrat, G.; Irache, J. M. Antimicrob. Agents Chemother., 2000, 44, 2190-2.
147. Hunter, R. L.; Jagannath, C.; Tinkley, A.; Behling, C. A.; Nolte, F. Antimicrob. Agents Chemother., 1995, 39, 435-9.
148. Jagannath, C.; Sepulveda, E.; Actor, J. K.; Luxem, F.; Emanuele, M. R.; Hunter, R. L. Immunopharmacology, 2000, 48, 185.
149. Newman, M. J.; Actor, J. K.; Balussubramian, M.; Jagannath, C. Crit. Rev. Ther. Drug Carrier Sys., 1998, 15, 89.
150. Blanco-Prieto, M.; Lecaroz, C.; Renedo, M.; Kunkova, J.; Gamazo, C. Int. J. Pharm., 2002, 242(1-2), 203.